Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALICAT: Extended LMWH for Cancer Associated Thrombosis
NCT01817257Phase 2Terminated
- Sponsor
- Cardiff University
- Start
- Dec 2013
- Primary completion
- Feb 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of low molecular weight heparin calcium in venous thromboembolism (VTE) (2 arms), sponsored by Cardiff University. Primary endpoints: Number of eligible and recruited patients at 12 months and Proportion of participants with recurrent VTEs at 24 months. Started Dec 2013; status: terminated.
02
Drugs
low molecular weight heparin calcium
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01817257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01817257.